|
시장보고서
상품코드
1908003
보톡스 시장 : 용도별, 제제별, 최종 사용자별, 성별, 연령층별, 유통채널별, 지역별Botox Market, By Application, By Formulation, By End User,By Gender, By Age Group, By Distribution Channel, By Geography |
||||||
세계의 보톡스 시장은 2025년 62억 1,000만 달러로 추정되었으며며, 2032년까지 125억 7,000만 달러에 이를 것으로 예측됩니다. 2025년부터 2032년까지는 연평균 복합 성장률(CAGR) 10.6%를 보일 것으로 예측됩니다.
| 보고서 내용 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준 연도: | 2024년 | 2025년 시장 규모: | 62억 1,000만 달러 |
| 과거 데이터 대상 기간: | 2020-2024년 | 예측 기간: | 2025-2032년 |
| 예측 기간(2025-2032년) CAGR: | 10.60% | 2032년 예측: | 125억 7,000만 달러 |
세계의 보톡스 시장은 미용 의료 및 치료 분야에서 매우 중요한 부분을 차지하고 있습니다. 이것은 보툴리눔톡신(보톡스)가 다양한 의료 용도로 널리 채용되고 있기 때문입니다. 주로 보툴리눔 박테리아에서 추출되는 보톡스는 신경질환에 대한 초기 치료 용도에서 발전하여 현재는 세계 미용시술의 기반이 되고 있습니다. 본 시장은 안면 주름의 경감, 근경련 치료, 편두통 관리, 다한증 치료, 과활동 방광 치료 등 다양한 제제와 용도를 포함하고 있습니다.
저침습 미용시술의 수용 확대와 미용적 향상 및 치료적 효과에 대한 인식이 높아짐에 따라 선진국 및 신흥국 양방에서 시장 침투가 현저하게 확대되고 있습니다. 가처분 소득 증가, 라이프 스타일 기호의 변화, 그리고 미용 의식 촉진에 대한 소셜 미디어의 영향이 함께 시장 확대에 기여하고 있습니다.
게다가, 지속적인 R&D 노력은 혁신적인 제형을 개발하고 치료 적응증을 확대하고 시장 범위를 더욱 확대하고 있습니다. 첨단 주사 기술의 통합, 환자 안전 프로토콜 개선, 의료 종사자를 위한 교육 프로그램 강화로 치료 수준이 향상됨과 동시에 관련 위험이 줄어들고, 세계 여러 인구층에서 소비자 신뢰와 시장 보급이 촉진되고 있습니다.
시장 역학
세계의 보톡스 시장은 견조한 성장 궤도를 추진하는 여러 가지 강력한 요인들에 의해 주로 견인되고 있습니다. 비수술적 미용 치료에 대한 수요 증가가 가장 중요한 시장 성장 촉진요인으로, 회복 기간 단축, 위험 감소, 비용 효율성이 높기 때문에 소비자는 기존의 수술적 개입보다 저침습 치료를 더욱 선호하고 있습니다. 미용 용도를 넘어 보툴리눔툭신(보톡스)의 치료 적용 범위 확대(만성 편두통, 근경련, 과활동 방광, 각종 신경질환 치료 등)는 시장의 잠재 고객층을 대폭 확대했습니다. 특히 밀레니엄 세대나 Z세대에서 미용 의식이 높아짐과, 신흥 시장에서의 가처분 소득 증가가 함께 수요 증가를 계속적으로 추진하고 있습니다. 그러나, 제품 승인 및 투여 방법을 규제하는 엄격한 법규제 프레임워크와 같은 시장 진입 지연과 컴플라이언스 비용 증가로 이어지는 현저한 제약도 존재합니다.
높은 치료 비용은 가격에 민감한 소비자층의 접근을 제한하고 부적절한 투여와 관련된 잠재적인 부작용과 합병증은 의료 종사자와 환자 모두에게 심각한 우려 사항입니다. 또한, 특정 지역에서 위조 제품과 무자격 시술자의 존재는 시장의 신뢰성과 환자의 안전성을 손상시키는 요인이 되고 있습니다. 이러한 과제가 있지만, 개발도상국에서의 의료 인프라의 확충, 의료 투어리즘 증가, 젊은층에서 예방적 미용 치료의 수용 확대로부터, 큰 기회가 발생하고 있습니다. 지속성 제제, 병용 요법, 신규 투여 경로의 개발은 큰 성장 가능성을 지니고 있으며, 원격 의료 통합 및 개인화 치료 프로토콜은 업계 관계자에게 혁신적인 시장 확대의 길을 제공합니다.
본 조사의 주요 특징
- 이 보고서는 세계의 보톡스 시장에 대한 상세한 분석을 제공하며 2024년을 기준으로 예측 기간 중(2025-2032년) 시장 규모(10억 달러) 및 CAGR(%)을 나타냅니다.
- 또한 다양한 부문에서 잠재적인 수익 기회를 밝히고 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품의 발매 또는 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 이 보고서는 세계의 보톡스 시장에서 주요 기업을 다음 매개 변수를 기반으로 프로파일링합니다 - 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략
- 이 보고서의 인사이트는 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보를 기반으로 의사 결정을 내릴 수 있도록합니다.
- 본 세계의 보톡스 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계의 보톡스 시장 분석에 이용된 다양한 전략 매트릭스를 통해 의사결정을 쉽게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 범위
- 보고서 개요
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 환경
- 제품 발매 및 승인
- PEST 분석
- Porter's Five Forces 분석
- 인수합병 동향
- 업계 동향
제4장 세계의 보톡스 시장 : 용도별, 2020-2032년
- 미용 용도
- 치료 용도
제5장 세계의 보톡스 시장 : 제제별, 2020-2032년
- 액체 제제(즉시 사용 가능)
- 동결건조 분말(재구성품)
제6장 세계의 보톡스 시장 : 최종 사용자별, 2020-2032년
- 미용 클리닉
- 피부과 클리닉
- 병원
- 메디컬 스파
- 전문 및 신경학 센터
- 외래수술센터(ASC)
제7장 세계의 보톡스 시장 : 성별, 2020-2032년
- 여성
- 남성
제8장 세계의 보톡스 시장 : 연령층별, 2020-2032년
- 18-30세
- 31-45세
- 46-60세
- 60세 이상
제9장 세계의 보톡스 시장 : 유통 채널별, 2020-2032년
- 온라인
- 오프라인
제10장 세계의 보톡스 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제11장 경쟁 구도
- Allergan Aesthetics(AbbVie)
- Ipsen Pharma
- Galderma
- Merz Pharma
- Medytox Inc
- Daewoong Pharmaceutical Co Ltd
- Revance Therapeutics Inc
- Hugel Inc
- Lanzhou Institute of Biological Products Co Ltd
- Huons Biopharma Co Ltd
- Solstice Neurosciences LLC
- Supernus Pharmaceuticals
- Sinopharm Group
- Shanghai Fosun Pharmaceutical
- Huadong Medicine Co Ltd
- Sihuan Pharmaceutical Holdings Group Ltd
제12장 분석가 추천
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제13장 참고문헌 및 조사 방법
- 참고문헌
- 조사 방법
- 당사에 대해
Botox Market is estimated to be valued at USD 6.21 Bn in 2025 and is expected to reach USD 12.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 6.21 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 10.60% | 2032 Value Projection: | USD 12.57 Bn |
The global Botox market represents a pivotal segment within the aesthetic medicine and therapeutic treatment landscape, driven by the widespread adoption of botulinum toxin across diverse medical applications. Botox, primarily derived from Clostridium botulinum bacteria, has evolved from its initial therapeutic applications for neurological disorders to become a cornerstone of cosmetic procedures worldwide. The market encompasses various formulations and applications, including facial wrinkle reduction, muscle spasticity treatment, migraine management, hyperhidrosis therapy, and overactive bladder treatment.
The increasing acceptance of minimally invasive cosmetic procedures, coupled with growing awareness about aesthetic enhancement and therapeutic benefits, has significantly expanded market penetration across both developed and emerging economies. Rising disposable incomes, changing lifestyle preferences, and the influence of social media in promoting aesthetic consciousness have collectively contributed to market expansion.
Additionally, continuous research and development initiatives have led to innovative formulations and expanded therapeutic indications, further broadening the market scope. The integration of advanced injection techniques, improved patient safety protocols, and enhanced practitioner training programs has elevated treatment standards while reducing associated risks, thereby fostering greater consumer confidence and market adoption across various demographic segments globally.
Market Dynamics
The global Botox market is primarily driven by several compelling factors that collectively propel its robust growth trajectory. The increasing demand for non-surgical cosmetic procedures represents the most significant driver, as consumers increasingly prefer minimally invasive treatments over traditional surgical interventions due to reduced downtime, lower risks, and cost-effectiveness. The expanding therapeutic applications of botulinum toxin beyond cosmetic uses, including treatment for chronic migraines, muscle spasticity, overactive bladder, and various neurological conditions, have substantially broadened the market's addressable population. Growing awareness about aesthetic enhancement, particularly among the millennial and Gen-Z demographics, coupled with rising disposable incomes in emerging markets, continues to fuel demand acceleration. However, the market faces notable restraints including stringent regulatory frameworks governing product approval and administration, which can delay market entry and increase compliance costs.
The high cost of treatment sessions limits accessibility for price-sensitive consumer segments, while potential side effects and complications associated with improper administration pose significant concerns for both practitioners and patients. Additionally, the presence of counterfeit products and unqualified practitioners in certain regions undermines market credibility and patient safety. Despite these challenges, substantial opportunities emerge from expanding healthcare infrastructure in developing countries, increasing medical tourism, and growing acceptance of preventive aesthetic treatments among younger demographics. The development of longer-lasting formulations, combination therapies, and novel delivery mechanisms presents significant growth potential, while telemedicine integration and personalized treatment protocols offer innovative market expansion avenues for industry participants.
Key Features of the Study
- This report provides in-depth analysis of the global Botox market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Botox market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Allergan Aesthetics (AbbVie), Ipsen Pharma, Galderma, Merz Pharma, Medytox Inc, Daewoong Pharmaceutical Co Ltd, Revance Therapeutics Inc, Hugel Inc, Lanzhou Institute of Biological Products Co Ltd, Huons Biopharma Co Ltd, Solstice Neurosciences LLC, Supernus Pharmaceuticals, Sinopharm Group, Shanghai Fosun Pharmaceutical, Huadong Medicine Co Ltd, and Sihuan Pharmaceutical Holdings Group Ltd
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global Botox market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Botox market
Market Segmentation
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Aesthetic Applications
- Facial Wrinkle Treatment (e.g., glabellar lines, crow's feet, forehead lines)
- Other Aesthetic Enhancements (e.g., jaw slimming, gummy smile correction)
- Therapeutic Applications
- Chronic Migraine
- Muscle Spasticity (e.g., upper limb spasticity, cervical dystonia)
- Overactive Bladder & Neurogenic Detrusor Overactivity
- Hyperhidrosis (severe primary axillary sweating)
- Blepharospasm & Strabismus
- Other Therapeutic Uses (e.g., sialorrhea, bruxism)
- Formulation Insights (Revenue, USD Bn, 2020 - 2032)
- Liquid Formulation (Ready-to-Use)
- Lyophilized Powder (Reconstituted)
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Aesthetic Clinics
- Dermatology Clinics
- Hospitals
- Medical Spas
- Specialty and Neurology Centers
- Ambulatory Surgical Centers
- Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Female
- Male
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- 18-30 Years
- 31-45 Years
- 46-60 Years
- Above 60 Years
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Online
- Offline
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Allergan Aesthetics (AbbVie)
- Ipsen Pharma
- Galderma
- Merz Pharma
- Medytox Inc
- Daewoong Pharmaceutical Co Ltd
- Revance Therapeutics Inc
- Hugel Inc
- Lanzhou Institute of Biological Products Co Ltd
- Huons Biopharma Co Ltd
- Solstice Neurosciences LLC
- Supernus Pharmaceuticals
- Sinopharm Group
- Shanghai Fosun Pharmaceutical
- Huadong Medicine Co Ltd
- Sihuan Pharmaceutical Holdings Group Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Botox Market, By Application
- Global Botox Market, By Formulation
- Global Botox Market, By End User
- Global Botox Market, By Gender
- Global Botox Market, By Age Group
- Global Botox Market, By Distribution Channel
- Global Botox Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Botox Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Aesthetic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Facial Wrinkle Treatment (e.g., glabellar lines, crow's feet, forehead lines)
- Other Aesthetic Enhancements (e.g., jaw slimming, gummy smile correction)
- Therapeutic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chronic Migraine
- Muscle Spasticity (e.g., upper limb spasticity, cervical dystonia)
- Overactive Bladder & Neurogenic Detrusor Overactivity
- Hyperhidrosis (severe primary axillary sweating)
- Blepharospasm & Strabismus
- Other Therapeutic Uses (e.g., sialorrhea, bruxism)
5. Global Botox Market, By Formulation, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Liquid Formulation (Ready-to-Use)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Lyophilized Powder (Reconstituted)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Botox Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Aesthetic Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dermatology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Spas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty and Neurology Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Botox Market, By Gender, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Botox Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- 18-30 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 31-45 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- 46-60 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Above 60 Years
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Botox Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Botox Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Allergan Aesthetics (AbbVie)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Galderma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merz Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medytox Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Daewoong Pharmaceutical Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Revance Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hugel Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lanzhou Institute of Biological Products Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Huons Biopharma Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Solstice Neurosciences LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Supernus Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sinopharm Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Shanghai Fosun Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Huadong Medicine Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sihuan Pharmaceutical Holdings Group Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
